Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus

NCT05247203 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

BIOLOGICAL: Telitacicept
DRUG: standard therapy

Sponsor

RemeGen Co., Ltd.